| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00074 | 1 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |